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Abstract
Aims: To carry out an audit ascertaining the importance of condition of lymph node specimen,
submission of clinical history including site of biopsy and imrnunohistochemcial studies on
conclusiveness of diagnosis made.
Methodology: Computer records of the Aga Khan University Hospital, Histopathology Laboratory
were used to analyze all cases of lymphoproliferative malignancies presented at the hospital from 1992
to 1998.
Results: Out of a total of 466 cases studied, in 283 (61%) the lymph nodes were fragmented. The site
of biopsy was mentioned in 361 (77.5%) cases with the cervical region forming the most common site
(56.5%). A clinical history was submitted in 395 (85%) and a conclusive diagnosis was reached in 378
(81%) cases.
Conclusion: This audit indicates a strong co-relation between the condition of lymph node biopsies
received, clinical history of the patient submitted including site of biopsy, acvillary studies like IHC
performed on the eventual outcome in the form of precise diagnosis and categorization of
lymphoproliferative malignancies (JPMA 50:179, 2000).
Introduction
According to the Karachi-South Cancer Registry lymphoid malignancies like Hodgkin\'s and Non-I
lodgkin\'s lymphomas constitute the 3rd most common malignancy after cancers of the oral cavity,
pharynx, larynx and lungs1. An accurate and timely diagnosis of these specific lymphoid disorders goes
a long way in dealing effectively with the problem. Fortunately most of the lymphoid malignancies not
only respond very well to chemotherapy but are also potentially curable. Besides the expertise of the
pathologist in making proper histological diagnosis, there are several pre-requisites, which must he
fulfilled for an optimum tissue preparation and diagnosis, enabling the pathologist a correct
interpretation.
Usual problems are fragmented nature of the specimens, lack of clinical history, improper fixation and
failure to mention the site of biopsy. Nowadays ancillary procedures like Immunohistochemistry (IHC)
and molecular biology techniques play a major role towards an accurate diagnosis. When classifying
lymphoproliferative disorders it is crucial to remember that correct diagnosis can only be reached when
clinical data is integrated with histopathological, IHC and morphological features2.
Materials and Methods
Computer records at the AKUH Histopathology Laboratory were used for this audit. All 466 cases of
lymphomas from the years 1992 to 1998 diagnosed at AKUH were analyzed. In all cases the
parameters including age, sex, site of biopsy, clinical history, condition of the sample and IHC analysis
were studied and noted. The data was analyzed partly manualh and partly using computer softwares
Ms-Word and Harvard Graphics.
Results
Mean age of the patients was 43 years with a male to female ratio of 2.6: 1. The neck region was the

most common site of biopsy with 204 (56.5%) of the mentioned lymph node specimens followed by
axillary lymph nodes (13.9%) (Figure 1).

The site of lymph node biopsy was mentioned in 361 out of 466 cases (77.5%).
The percentage of cases where the site of biopsy was mentioned showed fluctuations over 7 years
although there was an overall increase from 61% in 1992 to 81% in 1998 (Figure 2).

The percentage of cases where clinical history was mentioned showed a fluctuating increase from 72%
in 1992 to 92% in 1998 (Figure 3).

The most dismal finding was the fragmented nature of the lymph node specimens which showed a
worsening upward trend from 50% in 1992 to 66% in 1998 (Figure 4).

Immunoh istochem ical studies were routinely started only after 1994 and remained more or less steady
from 41% in 1992 to 43% in 1998 (Figure 5).

There has been a marked increase in the percentage of cases where a conclusive diagnosis was reached,
increasing from 61% in 1992 to 87% in 1998 (Figure 6).

Discussion
Lymphadenopathy is a very common presenting symptom. It is a manifestation of many disease
processes ranging from self-limiting ones to those that are fatal 3. Lymph node biopsy is the main stay
in reaching a conclusive diagnosis in these cases. Precise diagnosis is directly proportional to the
quality of the material received as well as a clinical history of the patient. Most clinicians think that by
providing a piece of tissue to the pathologist they have done their duty and that the pathologist has all
the other ingredients to reach a precise diagnosis. Dangerous to mankind are the clinicians with this
concept and more so the pathologists who accept it.
In this audit the site of lymph node biopsy was not mentioned in 22.5% of the cases. This can be a
major hindrance for precise diagnosis and categorization of the lymphoproliferative lesions and hence
for the management of the patient and the prognosis of the disease. Specific examples can be cited
relating to the importance of the site of lymph node biopsy, for example, majority of Burkitt\'s
lymphomas and upto 40% of aggressive B-cell lymphomas are initially diagnosed on extranodal
locations 4. It is therefore of utmost importance that the biopsies which are sent in be labeled with the
specific site of biopsy to aid the pathologist in arriving at the correct diagnosis. To make a diagnosis on

tissue specimens without pertinent clinical information is identical to a situation where a physician is
asked to make a diagnosis without obtaining the clinical history from the patient. Diagnosis must be
made in the light of clinical history as the same histological features may be interpreted differently e.g.,
without clinical history instance following a fracture) may be identical to osteogenic sarcoma. With the
selection of the proper tests unnecessary or invasive treatments can be avoided. Ultimately when a
neoplastic process is suspected, a lymph node biopsy is the definitive test 3.
One of our major problems was that the majority of lymph nodes received were fragmented from 50%
in 1992 to 66% in 1998. This may be due to the increase in the number of cases during the same period
of time. However, it is a fact that the specimens of lymph nodes from labs throughout Pakistan sumitted
to our lab for evaluation are often in conditions that render diagnosis very difficult if not impossible.
even for very experienced pathologists. It is a fact that lymph node biopsies are usually left to the
junior most person of the department who at the end of the day struggles and takes out the lymph node
usually in bits and pieces. It is then expected from the pathologist to give a definite diagnosis on this
material.
Histology remains the first and most important step towards a relevant diagnosis 5. Recent
developments in technology with the availability of immunohistochemistry (IHC) makes it even more
important that the tissue received is intact and properly fixed. Over and under fixation may be
detrimental for the tissue resulting in sub—optimal IHC results leading to inconclusive diagnosis and a
lost opportunity to offer proper treatment and cure. In summary this is for sure that a little more respect
for the tissue by the clinicians, pathologists and all those who may come in between may be a
difference between life and death.
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